论文部分内容阅读
正当国内各大新闻媒体将“伟哥”话题炒得沸沸扬扬之时,3月29日国家医药监督管理局向全国发出紧急通知,通知称:美国“伟哥”在我国目前还处于临床研究阶段,至今尚未批准国内任何企业进口和生产“伟哥”药品,目前市场上销售的全部为假冒产品,一旦查出将严肃处置。4月15日,新华社一则消息:号称在美国人前抢注“伟哥”商标,并在全国掀起一阵新闻热点的沈阳飞龙制药有限公司生产的“伟哥开泰胶囊”属劣药,因擅改药品名称误导消费者而被国家药品监督局查处。就在“伟哥开泰”被淘汰出局之时,湖南岳阳一家中美合资企业湖南都瑞医药实业有限公司生产的“都瑞伟哥”却是风头正劲。自今年3月15日以来,该公司推出的“都瑞伟哥”迅速抢占各地市场。迄今
While the major news media in the country had heatedly talked about the topic of “Viagra”, on March 29, the State Drug Administration issued an emergency notice to the nation, stating that the US “Viagra” is still in the stage of clinical research in China and has not yet Approved any domestic company to import and produce “Viagra” medicines. All the products currently sold on the market are counterfeit products. Once detected, they will be disposed of seriously. On April 15, Xinhua News Agency reported that it was reported that the “Viagra” trademark was registered before the Americans and “Viagra Kaitai Capsule” produced by Shenyang Feilong Pharmaceutical Co., Ltd. was a hot topic in the country. Drug names were misled by consumers and investigated by the State Drug Administration. When “Viagra Kai Tai” was eliminated, “Duo Rui Wei Brother” produced by a Hunan-based Sino-U.S. joint venture Hunan Yueyang Pharmaceutical Industry Co., Ltd. was a headwind. Since March 15 this year, the company’s “Durui Viagra” has quickly seized the market. so far